
Nano-Oncology and Translational Therapeutics Unit
@oncologynano
Nano-Oncology and Translational Therapeutics Unit, Health Research Institute of Santiago de Compostela (IDIS), SERGAS. @mfuentefreire
ID: 1268930530814328832
http://www.idisantiago.es/areas-investigacion/a001-oncoloxia 05-06-2020 15:39:59
319 Tweet
292 Takipçi
292 Takip Edilen


The OASIs project EuroNanoMed Instituto de Salud Carlos III (ISCIII) Instituto de Invest. Sanitaria de Santiago (IDIS) has already started! The consortium involves experts from different disciplines Dr. María D. Mayán AliMobasheri LuminitaSimion Franck PAVAN and attracts the interest of companies DIVERSA Technologies elcorreogallego.es/santiago/nanot…

💊🔬 Novos tratamentos para a osteoartrite a través da nanotecnoloxía. Esa é a premisa da que parte o proxecto OASIs, coordinado por Maria de la Fuente do Instituto de Invest. Sanitaria de Santiago (IDIS) e coa colaboración do grupo de Dr. María D. Mayán do INIBIC. Máis detalles ⬇️ gciencia.com/investigacion/…

#ForoEconómicoGalicia | "La nanomedicina es futuro y presente. Hemos sido capaces de conseguir vacunas en un tiempo récord gracias a ella" explica María de la Fuente, CEO de DIVERSA Technologies youtube.com/watch?v=KgplBw…








Don't forget to take advantage of a 50% discount for first time customers! 📩Send an email to [email protected] 📢Or contact us via our website: cutt.ly/PHfWrOj


🏆 Queremos agradecer novamente ao Biólogos de Galicia por este recoñecemento, e polo evento do que puidemos desfrutar onte, ao que asistiron a nosa presidenta Elena Lendoiro e a nosa tesoureira ZuModeLaranxa. Prometemos seguir traballando a prol da investigación en Galicia!💪🏽


More specific, effective and personalized care – this is the future that #biomedical research enables, as explained in this article by El País English Edition. We contribute to the advances of modern science with our carrier technology! 💡 Discover more: english.elpais.com/science-tech/2…

“Nanoparticles...lead to entirely new classes of antibacterial and antiviral agents.” – the future lies in new #drugdelivery systems, as explained in this article by the @MHealthLab Our nanocarriers are already at the forefront of #biomedicine Read on👇 labblog.uofmhealth.org/lab-report/nan…


Great experience at the #ETPN2022 ETP Nanomedicine, meeting colleagues and participating in the General Assembly, “Is smart nanomedicine ready for the clinic?” roundtable, and Pitch-me-up session. I had the opportunity to indroduce DIVERSA Technologies to the nanomedicine community👇



El #cáncer constituye una de las mayores causas de mortalidad en el mundo🌏 Por ello, la #nanotecnología tiene mucho que aportar a los retos que presenta la #oncología🔬 👩⚕️Puedes ver la explicación de la Dra. Maria de la Fuente en el vídeo👇 youtube.com/watch?v=Jlx-QS… #BrainPills